Microbiology
-
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
This article has 30 authors:Reviewed by ScreenIT
-
Evolution and variation of 2019-novel coronavirus
This article has 4 authors:Reviewed by ScreenIT
-
Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant
This article has 3 authors:Reviewed by ScreenIT
-
Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating
This article has 6 authors:Reviewed by ScreenIT
-
Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2
This article has 8 authors:Reviewed by ScreenIT
-
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome
This article has 7 authors:Reviewed by ScreenIT
-
Broad-spectrum antiviral activity of 3D8, a nucleic acid-hydrolyzing single chain variable fragment (scFv), targeting SARS-CoV-2 and multiple coronaviruses in vitro
This article has 16 authors:Reviewed by ScreenIT
-
Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations
This article has 6 authors:Reviewed by ScreenIT
-
Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
This article has 20 authors:Reviewed by ScreenIT
-
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
This article has 64 authors:Reviewed by ScreenIT